Home
Scholarly Works
Assessment of Immune Checkpoint Inhibitors and...
Journal article

Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma

Abstract

This cohort study examines treatment with immune checkpoint inhibitors for patients with metastatic renal cell carcinoma.

Authors

Lalani A-KA; Bakouny Z; Farah S; Donskov F; Dudani S; Heng DYC; Choueiri TK

Journal

JAMA Oncology, Vol. 7, No. 5, pp. 773–775

Publisher

American Medical Association (AMA)

Publication Date

May 1, 2021

DOI

10.1001/jamaoncol.2021.0019

ISSN

2374-2437

Associated Experts

Aly-Khan Lalani

Associate Professor, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and carcinogenesis3204 Immunology

Medical Subject Headings (MeSH)

Body Mass IndexCarcinoma, Renal CellGenomicsHumansImmune Checkpoint InhibitorsKidney Neoplasms
View published work (Non-McMaster Users)
View published work (McMaster Users)

Contact the Experts team

Get technical help
or
Provide website feedback